Table 2.
Antimicrobial susceptibility of Klebsiella oxytoca.
| Antimicrobial agent | MIC (mg/mL) | SIR result |
|---|---|---|
| Ampicillin | >16 | R |
| Ampicillin/sulbactam | 8 | S |
| Amoxicillin/clavulanic acid | ≦ 8 | S |
| Piperacillin | 16 | S |
| Piperacillin-tazobactam | ≦ 8 | S |
| Cefazolin | >16 | R |
| Cefmetazole | ≦ 16 | S |
| Ceftriaxone | ≦ 1 | S |
| Cefepime | ≦ 2 | S |
| Cefoperazone/sulbactam | ≦ 16 | S |
| Meropenem | ≦ 1 | S |
| Amikacin | ≦ 4 | S |
| Sulfamethoxazole-trimethoprim | ≦ 2 | S |
| Levofloxacin | ≦ 0.5 | S |
Susceptibility testing of K. oxytoca was performed according to Clinical and Laboratory Standards Institute (CLSI) document (ver. 26).
I, intermediate; MIC, minimum inhibitory concentration; R, resistant; S, susceptible.